4-Chloro-6-cyclopropylpyrimidine

Catalog No.: 
ACELVZ654
CAS No.: 
7038-76-8
Molecular Formula: 
C7H7ClN2
Molecular Weight: 
154.60
4-Chloro-6-cyclopropylpyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$61.00In stockInquiry
250mg95%$116.00In stockInquiry
1g95%$313.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Chloro-6-cyclopropylpyrimidine
IUPAC Name4-chloro-6-cyclopropylpyrimidine
MDL No.MFCD09861748
Molecular FormulaC7H7ClN2
Molecular Weight154.60
SMILESClC1=NC=NC(C2CC2)=C1
InChI KeyQQWGJFXERXLUHI-UHFFFAOYSA-N
Synonym4-chloro-6-cyclopropylpyrimidine(SALTDATA: FREE);Pyrimidine, 4-chloro-6-cyclopropyl-
CAS No.7038-76-8
PubChem CID24902140

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACELVZ654 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAQNU854 route compound structure diagram
    ACAQNU854411235-57-9In Stock
  4. Then
  5. ACELVZ654 route product structure diagram
    ACELVZ6547038-76-8In Stock
Inquiry

2. ACELVZ654 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACGIYB270 route compound structure diagram
    ACGIYB270126401-90-9In Stock
  2. Plus
  3. ACAQNU854 route compound structure diagram
    ACAQNU854411235-57-9In Stock
  4. Then
  5. ACELVZ654 route product structure diagram
    ACELVZ6547038-76-8In Stock
Inquiry

3. ACELVZ654 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACELVZ654 route product structure diagram
    ACELVZ6547038-76-8In Stock
Inquiry

Comments (0)